Since last summer, former takeover target Lifeway Foods has become a growth story. Given steady sales growth, plus factors like new product launches and a fatory expansion, could drive a large increase in profitability. That said, execution risk remains, so even those bullish on this changed "story" may want to wait for further weakness before buying.
Lifeway Foods remains undervalued relative to its robust growth outlook, with a buy rating and a $27.52 price target—26% above current levels. LWAY delivered 24% GAAP revenue growth in 3Q 2025, beat guidance, and reiterated strong EBITDA targets despite ongoing factory upgrades and margin pressure. Family boardroom disputes and buyout speculation have pressured the stock, but institutional investors and management remain focused on long-term growth.
Lifeway Foods demonstrates strong long-term potential in the consumer packaged goods sector, driven by its kefir and farmers cheese products. LWAY has achieved significant revenue growth since mid-2024, showcasing resilience despite internal family drama and external takeover attempts. The company remains founder-led, which has contributed to its consistent execution and ability to navigate challenges effectively.
| Food Products Industry | Consumer Staples Sector | Julie Smolyansky CEO | XFRA Exchange | US5319141090 ISIN |
| US Country | 291 Employees | 28 Jun 2013 Last Dividend | 16 Aug 2006 Last Split | 29 Sep 1987 IPO Date |
Lifeway Foods, Inc., established in 1986 and headquartered in Morton Grove, Illinois, is a leading producer and marketer of probiotic-based products not only in the United States but also internationally. The company is renowned for its innovative approach to developing health-focused dairy products, leveraging the benefits of probiotics to cater to health-conscious consumers. Lifeway's commitment to quality and health benefits is evident in its wide range of products, with drinkable kefir being its flagship offering. Lifeway Foods, Inc. operates under its name and additional brand names such as GlenOaks Farms and Fresh Made, expanding its market reach through a combination of direct sales force, brokers, and distributors. The company also offers its manufacturing capabilities to create products under private labels, thereby serving a diverse customer base with its probiotic offerings.